These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 11319922

  • 21. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.
    Cancer Lett; 2010 Feb 01; 288(1):17-27. PubMed ID: 19604626
    [Abstract] [Full Text] [Related]

  • 22. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
    Geller AI, Yu L, Wang Y, Fraefel C.
    Exp Neurol; 1997 Mar 01; 144(1):98-102. PubMed ID: 9126158
    [Abstract] [Full Text] [Related]

  • 23. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
    Stavropoulos TA, Strathdee CA.
    J Virol; 1998 Sep 01; 72(9):7137-43. PubMed ID: 9696807
    [Abstract] [Full Text] [Related]

  • 24. A modular set of helper-dependent herpes simplex virus expression vectors.
    Strathdee CA, McLeod MR.
    Mol Ther; 2000 May 01; 1(5 Pt 1):479-85. PubMed ID: 10933969
    [Abstract] [Full Text] [Related]

  • 25. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
    Johnston KM, Jacoby D, Pechan PA, Fraefel C, Borghesani P, Schuback D, Dunn RJ, Smith FI, Breakefield XO.
    Hum Gene Ther; 1997 Feb 10; 8(3):359-70. PubMed ID: 9048203
    [Abstract] [Full Text] [Related]

  • 26. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
    Lee CY, Bu LX, Rennie PS, Jia WW.
    Cancer Gene Ther; 2007 Jul 10; 14(7):652-60. PubMed ID: 17479106
    [Abstract] [Full Text] [Related]

  • 27. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
    Yang T, Wang X, Yan Z, Hou Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec 10; 11(4):306-10. PubMed ID: 15617234
    [Abstract] [Full Text] [Related]

  • 28. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
    Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F, Tsurumi T, Nishiyama Y.
    Cancer Gene Ther; 2007 Nov 10; 14(11):918-26. PubMed ID: 17693992
    [Abstract] [Full Text] [Related]

  • 29. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
    Bowers WJ, Howard DF, Brooks AI, Halterman MW, Federoff HJ.
    Gene Ther; 2001 Jan 10; 8(2):111-20. PubMed ID: 11313780
    [Abstract] [Full Text] [Related]

  • 30. Modest increases in the titers of helper virus-free herpes simplex virus 1 (HSV-1) vectors by packaging in a cell line with inducible expression of HSV-1 VP16 or by treatment with N,N'-hexamethylene-bis-acetamide.
    Sun M, Lee J, Yu L, Geller AI.
    Acta Virol; 2000 Dec 10; 44(6):365-9. PubMed ID: 11332280
    [Abstract] [Full Text] [Related]

  • 31. An efficient selection system for packaging herpes simplex virus amplicons.
    Zhang X, O'Shea H, Entwisle C, Boursnell M, Efstathiou S, Inglis S.
    J Gen Virol; 1998 Jan 10; 79 ( Pt 1)():125-31. PubMed ID: 9460933
    [Abstract] [Full Text] [Related]

  • 32. Herpes simplex virus amplicon: effect of size on replication of constructed defective genomes containing eucaryotic DNA sequences.
    Kwong AD, Frenkel N.
    J Virol; 1984 Sep 10; 51(3):595-603. PubMed ID: 6088785
    [Abstract] [Full Text] [Related]

  • 33. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
    Grant KG, Krisky DM, Ataai MM, Glorioso JC.
    Biotechnol Bioeng; 2009 Mar 01; 102(4):1087-97. PubMed ID: 18828174
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. HSV-1 infected cell proteins influence tetracycline-regulated transgene expression.
    Herrlinger U, Pechan PA, Jacobs AH, Woiciechowski C, Rainov NG, Fraefel C, Paulus W, Reeves SA.
    J Gene Med; 2000 Mar 01; 2(5):379-89. PubMed ID: 11045432
    [Abstract] [Full Text] [Related]

  • 38. Analysis of two potential shuttle vectors containing herpes simplex virus defective DNA.
    Bear SE, Colberg-Poley AM, Court DL, Carter BJ, Enquist LW.
    J Mol Appl Genet; 1984 Mar 01; 2(5):471-84. PubMed ID: 6090565
    [Abstract] [Full Text] [Related]

  • 39. Examination of conditions affecting the efficiency of HVS-1 amplicon packaging.
    Wu X, Leduc Y, Cynader M, Tufaro F.
    J Virol Methods; 1995 Mar 01; 52(1-2):219-29. PubMed ID: 7769035
    [Abstract] [Full Text] [Related]

  • 40. Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes.
    Schmeisser F, Weir JP.
    BMC Biotechnol; 2007 May 14; 7():22. PubMed ID: 17501993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.